In 2023, Australia's pharmaceutical industry export market share stood at 0.65. Forecasted data for 2024 and onwards suggests a slight decline. The value remains constant at 0.65 for 2024 and 2025, then slightly decreases to 0.64 from 2026 to 2028. Year-on-year variation indicates a stable 0% change for 2024 and 2025, following a -1.54% decrease from 2025 to 2026 and stability through to 2028. The Compound Annual Growth Rate (CAGR) over the next five years is approximately -0.31%.
Future trends to watch for include potential shifts in global pharmaceutical demand, domestic policy changes, and advancements in biotechnology which could impact Australia’s competitive positioning in the export market.
